A detailed history of Essex Savings Bank transactions in Abb Vie Inc. stock. As of the latest transaction made, Essex Savings Bank holds 12,674 shares of ABBV stock, worth $2.1 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares
12,674
Previous 12,674 -0.0%
Holding current value
$2.1 Million
Previous $1.96 Million 17.46%
% of portfolio
0.62%
Previous 0.57%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 22, 2024

SELL
$137.6 - $154.97 $2,889 - $3,254
-21 Reduced 0.17%
12,674 $1.96 Million
Q3 2023

Oct 12, 2023

SELL
$133.59 - $154.65 $66,795 - $77,325
-500 Reduced 3.79%
12,695 $1.89 Million
Q2 2023

Jul 19, 2023

BUY
$132.51 - $164.9 $60,822 - $75,689
459 Added 3.6%
13,195 $1.78 Million
Q1 2023

Apr 24, 2023

BUY
$144.61 - $166.54 $25,595 - $29,477
177 Added 1.41%
12,736 $2.03 Million
Q4 2022

Jan 18, 2023

BUY
$138.31 - $165.87 $54,770 - $65,684
396 Added 3.26%
12,559 $0
Q3 2022

Oct 19, 2022

BUY
$134.21 - $153.93 $108,575 - $124,529
809 Added 7.13%
12,163 $1.63 Million
Q2 2022

Jul 19, 2022

SELL
$137.62 - $174.96 $74,452 - $94,653
-541 Reduced 4.55%
11,354 $1.74 Million
Q1 2022

May 03, 2022

BUY
$131.98 - $163.75 $313,056 - $388,415
2,372 Added 24.91%
11,895 $1.93 Million
Q4 2021

Feb 23, 2022

SELL
$107.43 - $135.93 $7,520 - $9,515
-70 Reduced 0.73%
9,523 $1.29 Million
Q3 2021

Oct 20, 2021

BUY
$106.4 - $120.78 $39,155 - $44,447
368 Added 3.99%
9,593 $1.16 Million
Q2 2021

Jul 29, 2021

BUY
$105.21 - $117.21 $39,453 - $43,953
375 Added 4.24%
9,225 $1.04 Million
Q1 2021

Apr 22, 2021

BUY
$102.3 - $112.62 $80,714 - $88,857
789 Added 9.79%
8,850 $953,000
Q4 2020

Feb 03, 2021

SELL
$80.49 - $108.67 $59,321 - $80,089
-737 Reduced 8.38%
8,061 $864,000
Q3 2020

Oct 26, 2020

BUY
$85.91 - $100.83 $114,689 - $134,608
1,335 Added 17.89%
8,798 $771,000
Q2 2020

Jul 30, 2020

BUY
$73.37 - $98.18 $39,473 - $52,820
538 Added 7.77%
7,463 $733,000
Q1 2020

Apr 28, 2020

SELL
$64.5 - $97.79 $89,977 - $136,417
-1,395 Reduced 16.77%
6,925 $528,000
Q4 2019

Feb 05, 2020

SELL
$72.13 - $90.25 $37,868 - $47,381
-525 Reduced 5.94%
8,320 $737,000
Q3 2019

Oct 30, 2019

SELL
$62.98 - $75.72 $196,308 - $236,019
-3,117 Reduced 26.06%
8,845 $670,000
Q2 2019

Aug 09, 2019

BUY
$65.7 - $83.98 $153,212 - $195,841
2,332 Added 24.22%
11,962 $870,000
Q4 2018

Feb 01, 2019

BUY
$77.85 - $96.01 $749,695 - $924,576
9,630 New
9,630 $888,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $293B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Essex Savings Bank Portfolio

Follow Essex Savings Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex Savings Bank, based on Form 13F filings with the SEC.

News

Stay updated on Essex Savings Bank with notifications on news.